Prikaz osnovnih podataka o dokumentu

dc.creatorMiljković, Đorđe
dc.creatorTrajković, Vladimir
dc.date.accessioned2023-07-31T10:45:45Z
dc.date.available2900-01-01
dc.date.issued2004
dc.identifier.issn1359-6101
dc.identifier.urihttp://radar.ibiss.bg.ac.rs/handle/123456789/6010
dc.description.abstractInterleukin-17 (IL-17) is a proinflammatory T cell cytokine presumably involved in physiological responses to infection, but also in immunopathology of autoimmune disorders such as rheumatoid arthritis. The proinflammatory action of IL-17 depends considerably on its ability to trigger the expression of inducible nitric oxide (NO) synthase (iNOS), an enzyme responsible for the generation of cytotoxic and immunoregulatory free radical NO. Here we discuss the role of IL-17 in the cytokine network controlling iNOS expression, and analyze signaling pathways employed by IL-17 for the initiation of iNOS gene transcription. We also propose biological consequences of IL-17-mediated NO release that could be relevant for the mechanisms or therapy of autoimmune and inflammatory disorders.sr
dc.language.isoensr
dc.publisherElseviersr
dc.relationMinistry of Science and Technology of the Republic of Serbia (Grants No. 1664 and 2020)sr
dc.rightsrestrictedAccesssr
dc.sourceCytokine and Growth Factor Reviewssr
dc.subjectNitric oxidesr
dc.subjectiNOSsr
dc.subjectAutoimmunitysr
dc.titleInducible nitric oxide synthase activation by interleukin-17sr
dc.typearticlesr
dc.rights.licenseARRsr
dc.rights.holder© 2003 Elsevier Ltd.sr
dc.citation.issue1
dc.citation.volume15
dc.identifier.doi10.1016/j.cytogfr.2003.10.003
dc.identifier.pmid14746811
dc.identifier.scopus2-s2.0-1642554789
dc.identifier.wos000220870300003
dc.citation.spage21
dc.citation.epage32
dc.type.versionpublishedVersionsr
dc.citation.rankaM21


Dokumenti

Thumbnail

Ovaj dokument se pojavljuje u sledećim kolekcijama

Prikaz osnovnih podataka o dokumentu